nitroxyl has been researched along with nitroglycerin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Galagan, ME; Kalvin'sh, IIa; Kubrina, LN; Kuzmanis, IaA; Mordvintsev, PI; Vanin, AF; Vedernikov, IuI | 1 |
Favaloro, JL; Irvine, JC; Kemp-Harper, BK; Widdop, RE | 1 |
Irvine, JC; Kemp-Harper, BK; Widdop, RE | 1 |
Andrews, KL; Chin-Dusting, JP; Farry, J; Jefferis, AM; Kemp-Harper, BK; Lumsden, NG | 1 |
4 other study(ies) available for nitroxyl and nitroglycerin
Article | Year |
---|---|
[Angeli salt as a producer of nitrogen oxide in animal tissues].
Topics: Animals; Blood Pressure; Electron Spin Resonance Spectroscopy; Free Radicals; Hemoglobins; Male; Mice; Nitric Oxide; Nitrites; Nitrogen Oxides; Nitroglycerin; Nitroprusside; Rats | 1990 |
Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae.
Topics: Animals; Aorta, Thoracic; Benzoates; Cyclic GMP-Dependent Protein Kinases; Cysteine; Drug Tolerance; Enzyme Inhibitors; Free Radical Scavengers; Hydrazines; Imidazoles; In Vitro Techniques; Male; Nitric Oxide; Nitric Oxide Donors; Nitrites; Nitrogen Oxides; Nitroglycerin; Oxadiazoles; Quinoxalines; Rats; Rats, Inbred WKY; Time Factors; Vasodilation | 2007 |
Chronic administration of the HNO donor Angeli's salt does not lead to tolerance, cross-tolerance, or endothelial dysfunction: comparison with GTN and DEA/NO.
Topics: Acetylcholine; Animals; Aorta; Cyclic GMP; Diethylamines; In Vitro Techniques; Male; Nitric Oxide Donors; Nitrites; Nitrogen Oxides; Nitroglycerin; Rats | 2011 |
Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance.
Topics: Cyclic GMP; Dose-Response Relationship, Drug; Drug Tolerance; Enzyme Inhibitors; Guanylate Cyclase; Humans; In Vitro Techniques; Nitric Oxide Donors; Nitrites; Nitrogen Oxides; Nitroglycerin; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Radial Artery; Receptors, Cytoplasmic and Nuclear; Saphenous Vein; Soluble Guanylyl Cyclase; Vasodilation; Vasodilator Agents | 2015 |